Paradox Immunotherapeutics secures $10 Million investment from SymBiosis to advance therapies for protein misfolding diseases
Find out how Paradox is revolutionizing treatment options for protein misfolding disease through innovative antibody technology.
Three McMaster professors awarded fellowships to grow their life science startups
Discover the winners of the 2025 McMaster Professor Entrepreneur Fellowship and their commitment to turning ideas into real impact.
Launchit Solutions completes acquisition of 2Gen Digital
LSI enhances its capabilities with the acquisition of 2Gen, benefiting healthtech innovators and organizations across Canada.
Vessl Prosthetics secures oversubscribed pre-seed funding to drive innovation in prosthetic solutions
This funding will enable Vessl to accelerate the development of its cutting-edge prosthetic devices, advancing the company’s mission to empower amputees to live fuller, more independent lives.
Sudbury’s Verv Technologies receives funding for blood-testing device
Verv Technologies is advancing the development of their medical device for in-home blood tests with funding from the Sudbury Catalyst Fund.
EMN raises Series A funding to revolutionize nutrition for surgery
Enhanced Medical Nutrition raises $5M Series A to expand ENROUTE®, a groundbreaking nutrition program improving surgical outcomes through innovation and care.
Launchit Solutions expands healthcare portfolio with acquisition of MedStack Inc., accelerating innovation in privacy-compliant health tech solutions
Launchit Solutions acquires MedStack to boost secure, compliant software for digital health, accelerating regulatory-ready solutions in healthcare innovation.
AgeRate and Alively partner for biological age testing accessibility
The partnership between AgeRate and Alively marks a significant step forward to increase the accessibility of personalized health insights.
OBIO® and St. Joseph’s Healthcare partner with Technology Trace to evaluate trevii medical asset management platform
Technology Trace Inc. partners with St. Joe’s Hamilton to use the trevii platform for better medical asset utilization and patient flow.
Afynia Labs announces $2 million CAD to bring endometriosis test to market
Hamilton-based femtech company Afynia Labs, led by former McMaster scientists, is on a mission to improve how endometriosis is diagnosed.